Implementation of a gene therapy education initiative by the ASGCT and Muhimbili University of Health and Allied Sciences.
Journal
Molecular therapy : the journal of the American Society of Gene Therapy
ISSN: 1525-0024
Titre abrégé: Mol Ther
Pays: United States
ID NLM: 100890581
Informations de publication
Date de publication:
06 09 2023
06 09 2023
Historique:
received:
02
03
2023
revised:
04
06
2023
accepted:
24
07
2023
pmc-release:
06
09
2024
medline:
11
9
2023
pubmed:
19
8
2023
entrez:
18
8
2023
Statut:
ppublish
Résumé
There has been rapid growth in gene therapy development with an expanding list of approved clinical products. Several therapies are particularly relevant to patients in low- and middle-income countries. Moreover, investing in research and manufacturing presents an opportunity for economic development. To increase awareness of gene therapy, the American Society of Gene and Cell Therapy partnered with the Muhimbili University of Health and Allied Sciences, Tanzania, to create a certificate-bearing course. The goal was to provide faculty teaching in graduate and medical schools with the tools needed to add gene therapy to the university curriculum. The first virtual course was held in October of 2022, and 45 individuals from 9 countries in Africa completed the training. The content was new to approximately two-thirds of participants, with the remaining third indicating that the course increased their knowledge base. The program was well received and will be adapted for other under-resourced regions.
Identifiants
pubmed: 37595584
pii: S1525-0016(23)00399-4
doi: 10.1016/j.ymthe.2023.07.019
pmc: PMC10492022
pii:
doi:
Types de publication
Letter
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2561-2565Informations de copyright
Copyright © 2023 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.
Références
Mol Genet Genomic Med. 2019 Jul;7(7):e00776
pubmed: 31131548
AIDS Res Hum Retroviruses. 2019 Jul;35(7):649-659
pubmed: 30990052
Mol Ther. 2018 Dec 5;26(12):2715-2716
pubmed: 30454956
Mol Ther. 2022 Jun 1;30(6):2122-2129
pubmed: 35390542
Patient. 2020 Oct;13(5):633-642
pubmed: 32794073
Nat Biotechnol. 2017 Jun 7;35(6):491-492
pubmed: 28591128
N Engl J Med. 1990 Aug 30;323(9):570-8
pubmed: 2381442
Front Public Health. 2021 Nov 15;9:773175
pubmed: 34869185
J Natl Med Assoc. 2010 Dec;102(12):1123-8
pubmed: 21287892
J Community Genet. 2019 Jan;10(1):73-84
pubmed: 29589204
Am J Med Genet A. 2020 Jul;182(7):1716-1724
pubmed: 32449301